Skip to main content

Abstract

Myasthenia gravis and multiple sclerosis are both autoimmune diseases that affect the neuromuscular system. Patients affected by these two diseases are frequently women younger than 40 years old. Multiple sclerosis has a relapsing and remitting course, but both diseases course with progressive deterioration. Their effect on fertility has to do more with their effect on self-esteem, sexuality, and the therapies these patients require. This chapter reviews the physiopathology of these diseases, the effect of their treatments, and effect on fertility.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

Myasthenia Gravis (MG)

  1. Sussman J, Farrugia ME, Maddison P, Hill M, Leite MI, Hilton-Jones D. Myasthenia gravis: association of British Neurologists’ management guidelines. Practical neurology. 2015;15(3):199–206.

    Article  PubMed  Google Scholar 

  2. Binks S, Vincent A, Palace J. Myasthenia gravis: a clinical-immunological update. J Neurol. 2016;263(4):826–34.

    Article  CAS  PubMed  Google Scholar 

  3. Norwood F, Dhanjal M, Hill M, James N, Jungbluth H, Kyle P, et al. Myasthenia in pregnancy: best practice guidelines from a U.K. multispecialty working group. J Neurol Neurosurg Psychiatry. 2014;85(5):538–43.

    Article  PubMed  Google Scholar 

  4. Hurst RL, Gooch CL. Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis. Curr Neurol Neurosci Rep. 2016;16(7):61.

    Article  PubMed  Google Scholar 

  5. Wen JC, Liu TC, Chen YH, Chen SF, Lin HC, Tsai WC. No increased risk of adverse pregnancy outcomes for women with myasthenia gravis: a nationwide population-based study. Eur J Neurol. 2009;16(8):889–94.

    Article  PubMed  Google Scholar 

Multiple Sclerosis

  1. Amato MP, Portaccio E. Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs. CNS Drugs. 2015;29(3):207–20.

    Article  CAS  PubMed  Google Scholar 

  2. Compston A, Coles A. Multiple sclerosis. Lancet (London, England). 2008;372(9648):1502–17.

    Article  CAS  Google Scholar 

  3. Niedziela N, Adamczyk-Sowa M, Pierzchala K. Epidemiology and clinical record of multiple sclerosis in selected countries: a systematic review. Int J Neurosci. 2014;124(5):322–30.

    Article  PubMed  Google Scholar 

  4. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996;46(4):907–11.

    Article  CAS  PubMed  Google Scholar 

  5. Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sorensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278–86.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, et al. Escalating immunotherapy of multiple sclerosis--new aspects and practical application. J Neurol. 2004;251(11):1329–39.

    Article  CAS  PubMed  Google Scholar 

  7. Sorensen PS. New management algorithms in multiple sclerosis. Curr Opin Neurol. 2014;27(3):246–59.

    Article  PubMed  Google Scholar 

  8. Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 2006;5(11):932–6.

    Article  PubMed  Google Scholar 

  9. Sellner J, Kraus J, Awad A, Milo R, Hemmer B, Stuve O. The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors. Autoimmun Rev. 2011;10(8):495–502.

    Article  PubMed  Google Scholar 

  10. Chao MJ, Ramagopalan SV, Herrera BM, Orton SM, Handunnetthi L, Lincoln MR, et al. MHC transmission: insights into gender bias in MS susceptibility. Neurology. 2011;76(3):242–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Marrie RA, Cutter G, Tyry T, Hadjimichael O, Campagnolo D, Vollmer T. Changes in the ascertainment of multiple sclerosis. Neurology. 2005;65(7):1066–70.

    Article  CAS  PubMed  Google Scholar 

  12. Cavalla P, Rovei V, Masera S, Vercellino M, Massobrio M, Mutani R, et al. Fertility in patients with multiple sclerosis: current knowledge and future perspectives. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2006;27(4):231–9.

    CAS  Google Scholar 

  13. Nortvedt MW, Riise T, Myhr KM, Landtblom AM, Bakke A, Nyland HI. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult Scler (Houndmills, Basingstoke, England). 2001;7(4):231–5.

    Article  CAS  Google Scholar 

  14. Borello-France D, Leng W, O'Leary M, Xavier M, Erickson J, Chancellor MB, et al. Bladder and sexual function among women with multiple sclerosis. Mult Scler (Houndmills, Basingstoke, England). 2004;10(4):455–61.

    Article  Google Scholar 

  15. Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfigli L, et al. Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups. Mult Scler (Houndmills, Basingstoke, England). 1999;5(6):418–27.

    CAS  Google Scholar 

  16. Hellwig K, Correale J. Artificial reproductive techniques in multiple sclerosis. Clin Immunol. 2013;149(2):219–24.

    Article  CAS  PubMed  Google Scholar 

  17. Hellwig K, Schimrigk S, Beste C, Muller T, Gold R. Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur Neurol. 2009;61(2):65–8.

    Article  PubMed  Google Scholar 

  18. Sandberg-Wollheim M, Frank D, Goodwin TM, Giesser B, Lopez-Bresnahan M, Stam-Moraga M, et al. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology. 2005;65(6):802–6.

    Article  CAS  PubMed  Google Scholar 

  19. Lu E, Zhu F, Zhao Y, van der Kop M, Sadovnick AD, Synnes A, et al. Birth outcomes of pregnancies fathered by men with multiple sclerosis. Mult scler (Houndmills, Basingstoke, England). 2014;20(9):1260–4.

    Article  CAS  Google Scholar 

  20. Cocco E, Sardu C, Gallo P, Capra R, Amato MP, Trojano M, et al. Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study. Mult Scler (Houndmills, Basingstoke, England). 2008;14(9):1225–33.

    Article  CAS  Google Scholar 

  21. Meistrich ML, Wilson G, Mathur K, Fuller LM, Rodriguez MA, McLaughlin P, et al. Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease. J Clin Oncol Off J Am Soc Clin Oncol. 1997;15(12):3488–95.

    Article  CAS  Google Scholar 

  22. Awad A, Stuve O. Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms. Ther Adv Neurol Disord. 2009;2(6):50–61.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Watson AR, Rance CP, Bain J. Long term effects of cyclophosphamide on testicular function. Br Med J (Clin Res Ed). 1985;291(6507):1457–60.

    Article  CAS  Google Scholar 

  24. Vukusic S, Marignier R. Multiple sclerosis and pregnancy in the treatment era. Nat Rev Neurol. 2015;11(5):280–9.

    Article  PubMed  Google Scholar 

  25. McCombe PA, Stenager E. Female infertility and multiple sclerosis: is this an issue? Multiple sclerosis (Houndmills, Basingstoke, England). 2015;21(1):5–7.

    Google Scholar 

  26. Voskuhl RR, Gold SM. Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol. 2012;8(5):255–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Grinsted L, Heltberg A, Hagen C, Djursing H. Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. J Intern Med. 1989;226(4):241–4.

    Article  CAS  PubMed  Google Scholar 

  28. Marrie RA, Yu BN, Leung S, Elliott L, Warren S, Wolfson C, et al. The incidence and prevalence of thyroid disease do not differ in the multiple sclerosis and general populations: a validation study using administrative data. Neuroepidemiology. 2012;39(2):135–42.

    Article  PubMed  Google Scholar 

  29. Gnoth C, Godehardt E, Frank-Herrmann P, Friol K, Tigges J, Freundl G. Definition and prevalence of subfertility and infertility. Hum Reprod (Oxford, England). 2005;20(5):1144–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Goetsch, A.L., Kimelman, D., Woodruff, T.K. (2017). Autoimmune Diseases: Myasthenia Gravis and Multiple Sclerosis. In: Fertility Preservation and Restoration for Patients with Complex Medical Conditions. Springer, Cham. https://doi.org/10.1007/978-3-319-52316-3_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52316-3_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52315-6

  • Online ISBN: 978-3-319-52316-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics